Department of Pharmaceutical Outcomes and Policy, University of Florida, Florida, United States
Disclosure information not submitted.
3B-05 - Risk of Major Adverse Cardiovascular Events in Patients Receiving Roflumilast for the Treatment of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study Using Target Trial Emulation Framework
Monday, August 25, 20259:15 AM - 9:30 AM ET
